• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

An attempt to clarify the cause of "Pokkuri disease", a special type of sudden cardiac death, via Forensic Medicine.

Research Project

Project/Area Number 14570396
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Legal medicine
Research InstitutionTokai University

Principal Investigator

TAKEICHI Sanae  Tokai University, School of Medicine, Professor, 医学部, 教授 (20035497)

Co-Investigator(Kenkyū-buntansha) NAKAJIMA Katuyuki  Japan Immunoresearch Laboratory Co.,Ltd, Director, 開発部長(研究職)
GOTOH Shinya  Tokai University, School of Medicine, Associate Professor, 医学部, 助教授 (50225653)
SATOH Fumiko  Tokai University, School of Medicine, Assistant Researcher, 医学部, 助手 (70328128)
Project Period (FY) 2002 – 2003
KeywordsPokkuri disease / Remnant lipoproteins (RLP) / Sudden Coronary Death / Coronary Spasm / NO / Rho-kinase / Postmortem stability / Pregnancy
Research Abstract

Our present research has revealed the following new facts related to coronary spasm, which we believe is the direct cause of Pokkkuri disease.
1.We have clarified the role of endothelium-derived nitric oxide (NO)on coronary artery spasm by RLP isolated from the sudden cardiac death(SCD) cases. NO production in bovine endothelial cells was inhibited by RLP in a dose dependent manner. The amount of NO synthase (eNOS) was not dicreased, but the enzyme activity was suppressed by RLP.
2.Recently the increased activity of Rho-kinase in vascular smooth muscle cells has been known to play a major role in the pathogenesis of coronary artery spasm. Our in vivo study demonstrated that long -term treatment with RLP, but not with nascent VLDL from patients with SOD markedly enhanced coronary vasospastic activity in porcine coronary arteries. We then demonstrated in cultured human coronary vascular smooth muscle cells that the treatment of RLP significantly enhanced the expression and activation of Rho-kinase. Rho-kinase inhibitor, hydoxyfasdil completely inhibited this effect.
3.Validity of postmortem plasma remnant lipoprotein assay was studied in order to confirm the analysis of postmortem plasma. The postmortem alteration of lipids and lipoproteins were observed by the following methods ; Dry Chem TG and Determiner L-TG assay, HPLC profile analysis, electrophoresis, electron microscopy and rabbit ante-and postmortem plasma. We found that plasma lipid and lipoprotein levels determined in postmortem state did not differ significantly from antemortem levels
In addition to the above results
4.We have found that hypertriglyceridemia in pregnancy did not contribute to the elevation of RLP-C/VLDL-C ratio and RLP-TG/VLDL-TG ratio. These ratios were significantly low in pregnancy compared with diabetic patients and other cardiovascular disease. These results strongly point to the fact that Pokkuri disease is more common in males than in females.

  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Takeichi S.他5名: "Plasma remnant lipoprotein(RLP) in cases of Pokkuri disease"Program & Abstracts of Symposium Advanced in Legal Medicine. 122 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakajima Y., Takeichi S.他5名: "TG-UV assay applied to serum remnant lipoprotein-TG(RLP-TG) asasy"Clinical Chemistry & Laboratory Medicine. Suppl 40. S149 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimokawa H.他8名: "Remnant lipoproteins from patients with sudden death without significant coronary stenosis(Pokkuri disease) enhances coronary vasospastic activity through upregulation of Rho-kinase"Circulation. Suppl II. 106 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 武市早苗, 他3名: "ポックリ病における血漿RLP-TGについて"動脈硬化. 34回抄録集. 193 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 中島康洋, 武市早苗, 他7名: "死体血における血漿レムナント・リポ蛋白の安定性について"日本法医学会雑誌. 56(1). 106 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 武市早苗, 他7名: "ポックリ病の原因究明にむけて〜レムナントの冠動脈外膜を介する攣縮作用〜"第71回日本法医学会関東地方会講演要旨集. 28 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oi K., 他9名: "Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase"Arteriolosclerosis, thrombosis and Vascular Biology. In Press. (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Okazaki m., 他6名: "Hypertriglyceridemia in pregnancy dode not contribute to the enhanced formation of remnant lipoprotein particles"Clin.Chim.Acta. 339. 169-181 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takeichi S.他6名: "Valodity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death"Clin.Chim.Acta. In press. (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohara N., Takeichi S.他5名: "Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation"Clin.Chim.Acta. 338. 151-156 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 武市早苗, 他7名: "ポックリ病の原因究明に向けて-レムナントのRho-kinaseを介する冠攣縮作用の証明"日本法医学会雑誌. 57(1). 102 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takeichi S., Nakajima Y., Yukawa N., Fujita M.Q., Saito T., Satoh F., Steo Y, Kusakabe T., Jin ZB., Hasegawa I., Nakano T., Saniabadi A., Adachi M., Ohara N., Usui S., Okazaki M., Nakajima K.: "Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death"Clin.Chim.Acta. (In press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oi K., Hiroki J., Uwatoku T., Abe K., Matsumoto Y., Nakajima Y, Nakajima K., Takeshita A., Takeichi S., Shimokawa H.: "Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase."Arteriosclerosis Thrombosis and Vascular Biology. (In press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okazaki M., Usui S., Tokunaga K., Nakajima Y., Takeichi S., Nakano T., Nakajima K.: "Hypertrigriceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles."Clin.Chim.Acta. 339. 169-181 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ohara N., Takeichi S., Naito Y., Nakajima Y., Yukawa N., Nakano T., Nakajima K.: "Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation"Clin.Chim.Acta. 338(1-2). 151-156 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimokawa, H., Qi, K., Hiroki, J., Uwatoku, T., Abe, K, Matsumoto, Y., Nakajima, Y., Nakajima, K., Takeichi, S.: "Remnant lipoproteins from patients with sudden death without significant coronary stenosis (Pokuuri disease) enhances coronary vasospestic activity through upregulation of Rho-kinase."Circulation supple II. 106. II-172 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takeichi, S., Nakajima, Y, Satoh, F., Saito, T., Seto, Y., Yukawa, N.: "Plasma remnant lipoprotein (RLP) in cases of Pokkuri disease."5th international Symposium on Advanced in Legal Medicine Program & Abstracts.. 122. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakajima, Y., Takeichi, S., Satoh, F., Yamashita, K., Kishi, K., Nakano, T., Nakajima, K.: "TG-UV assay applied to serum remnant lipoprotein-TG (RLP-TG) assay."Clinical chemistry and laboratory medicine with supple.. 40. S149 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi